Veraxa Biotech AG (VRXA)
NASDAQ: VRXA · Real-Time Price · USD
0.9522
+0.0022 (0.23%)
At close: Nov 5, 2026, 4:00 PM EST
0.9712
+0.0190 (2.00%)
After-hours: Nov 5, 2026, 7:43 PM EST
Veraxa Biotech AG Revenue
In the year 2025, Veraxa Biotech AG had annual revenue of 23.43K CHF. That makes Veraxa Biotech AG the 46,864th largest company in the world by revenue and 7,045th in the United States.
Revenue (ttm)
23.43K CHF
Revenue Growth
n/a
P/S Ratio
4,557.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
134.65M USD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 23.43K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
VRXA News
- 23 days ago - Veraxa Biotech presents in vivo, in vitro data for BiTAC-ADC technology platform - TheFly
- 23 days ago - VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC®-ADC Technology at World ADC Congress - GlobeNewsWire
- 4 weeks ago - Micro-Cap Stock Veraxa Biotech Is Down 96% This Year. Can Next-Gen Drug Testing Save It? - Barrons
- 4 weeks ago - Veraxa Biotech to implement FDA-aligned NAMs across development programs - TheFly
- 4 weeks ago - VERAXA Biotech Provides Overview on Implementation of FDA-Aligned Human-Relevant Models into R&D Strategy - GlobeNewsWire
- 2 months ago - Veraxa Biotech appoints Raju Willener as CFO - TheFly
- 2 months ago - VERAXA Biotech Appoints Raju Willener as Chief Financial Officer - GlobeNewsWire
- 2 months ago - Veraxa Biotech, Secarna announce initial results from AOC alliance - TheFly